TMCI logo

Treace Medical Concepts (TMCI) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 April 2021

Indexes:

Not included

Description:

Treace Medical Concepts, Inc. specializes in innovative medical devices for foot and ankle surgery. The company focuses on improving surgical outcomes with its advanced technologies, particularly in treating bunions. Their products aim to enhance patient recovery and provide surgeons with effective tools for better results.

Key Details

Price

$8.56

Annual Revenue

$187.12 M(+31.92% YoY)

Annual EPS

-$0.81(-5.19% YoY)

Annual ROE

-49.91%

Beta

2.43

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 05, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

06 Nov '24 Stifel
Hold
14 Oct '24 Truist Securities
Hold
07 Aug '24 UBS
Neutral
07 Aug '24 Truist Securities
Hold
16 July '24 Truist Securities
Hold
15 July '24 Morgan Stanley
Equal-Weight
16 May '24 UBS
Neutral
08 May '24 UBS
Buy
08 May '24 Truist Securities
Hold
08 May '24 Stifel
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Help The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Help The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Help The Schall Law Firm
TMCI
accesswire.com25 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Violating Securities Laws
The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Violating Securities Laws
The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Violating Securities Laws
TMCI
accesswire.com24 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Affected Investors Are Invited To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Affected Investors Are Invited To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Affected Investors Are Invited To Contact The Schall Law Firm
TMCI
accesswire.com23 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations
The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations
The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations
TMCI
accesswire.com20 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm
TMCI
accesswire.com19 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Treace Announces Participation at Stifel 2024 Healthcare Conference
Treace Announces Participation at Stifel 2024 Healthcare Conference
Treace Announces Participation at Stifel 2024 Healthcare Conference
TMCI
globenewswire.com18 November 2024

PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ®  and Adductoplasty ®  Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, beginning at approximately 8:00 am ET.

Treace Medical Concepts, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm
Treace Medical Concepts, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm
TMCI
accesswire.com17 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations
TMCI
accesswire.com16 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
TMCI
accesswire.com15 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
TMCI
accesswire.com13 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

FAQ

  • What is the primary business of Treace Medical Concepts?
  • What is the ticker symbol for Treace Medical Concepts?
  • Does Treace Medical Concepts pay dividends?
  • What sector is Treace Medical Concepts in?
  • What industry is Treace Medical Concepts in?
  • What country is Treace Medical Concepts based in?
  • When did Treace Medical Concepts go public?
  • Is Treace Medical Concepts in the S&P 500?
  • Is Treace Medical Concepts in the NASDAQ 100?
  • Is Treace Medical Concepts in the Dow Jones?
  • When was Treace Medical Concepts's last earnings report?
  • When does Treace Medical Concepts report earnings?
  • Should I buy Treace Medical Concepts stock now?

What is the primary business of Treace Medical Concepts?

Treace Medical Concepts, Inc. specializes in innovative medical devices for foot and ankle surgery. The company focuses on improving surgical outcomes with its advanced technologies, particularly in treating bunions. Their products aim to enhance patient recovery and provide surgeons with effective tools for better results.

What is the ticker symbol for Treace Medical Concepts?

The ticker symbol for Treace Medical Concepts is NASDAQ:TMCI

Does Treace Medical Concepts pay dividends?

No, Treace Medical Concepts does not pay dividends

What sector is Treace Medical Concepts in?

Treace Medical Concepts is in the Healthcare sector

What industry is Treace Medical Concepts in?

Treace Medical Concepts is in the Medical Devices industry

What country is Treace Medical Concepts based in?

Treace Medical Concepts is headquartered in United States

When did Treace Medical Concepts go public?

Treace Medical Concepts's initial public offering (IPO) was on 23 April 2021

Is Treace Medical Concepts in the S&P 500?

No, Treace Medical Concepts is not included in the S&P 500 index

Is Treace Medical Concepts in the NASDAQ 100?

No, Treace Medical Concepts is not included in the NASDAQ 100 index

Is Treace Medical Concepts in the Dow Jones?

No, Treace Medical Concepts is not included in the Dow Jones index

When was Treace Medical Concepts's last earnings report?

Treace Medical Concepts's most recent earnings report was on 5 November 2024

When does Treace Medical Concepts report earnings?

The next expected earnings date for Treace Medical Concepts is 27 February 2025

Should I buy Treace Medical Concepts stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions